Recent Patents and Advances on Nanotechnologies against Coronavirus

Author(s): Roozbeh Abedini-Nassab*, Naeemeh Mahdaviyan

Journal Name: Recent Patents on Nanotechnology

Volume 15 , Issue 4 , 2021

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is one of the seven known coronaviruses infecting humans; HKU1, 229E, NL63, OC43, Acute Respiratory Syndrome Coronavirus (SARS-CoV), Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and SARS-CoV-2, the last three of which can cause severe symptoms in patients. COVID-19, previously known as 2019 novel coronavirus, caused by SARS-CoV-2, was first reported in Wuhan, China, in late 2019, and quickly resulted in a major epidemic across the world. Although the origin of SARS-CoV-2 is not clear yet, genome sequencing results suggest that this is the third reported spillover of an animal coronavirus to humans, from 2002. The development of detection, therapeutic, and prevention strategies for COVID-19 is a fundamental task towards curing infected people and competing with the pandemic. Because of their similarities, scientists believe that treatment/ detection methods similar to what were used against the illnesses caused by SARS-CoV or MERS-CoV may be effective for curing/detecting COVID-19. Here, we review the recent nanotechnology techniques used for treating and testing SARS-CoV, MERS-CoV, and SARS-CoV-2, and potential therapeutic options for curing COVID-19. This patent summarizes the recent findings of advances on Nanotechnologies against Coronavirus.

Keywords: Nanotechnology, biomedicine, COVID-19, SARS-CoV-2, SARS-CoV, MERS-CoV.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2021
Published on: 10 November, 2020
Page: [322 - 330]
Pages: 9
DOI: 10.2174/1872210514666201110125536
Price: $65

Article Metrics

PDF: 480